Riskpilot← Back to searchSign inGet full accessNexborn Fysioterapi AB
ABActiveOrg 5569814089Stampgatan 64 Lght 1601Physiotherapy activities · NACE 8695Est. 20141 employees
Revenue 2025
SEK 1,3M
-4% vs 2024
EBITDA margin
17.1%
-28% vs 2024
Equity ratio
75.0%
Financial strength
Net profit 2025
SEK 180K
-27% vs 2024
| Revenue | SEK 1,3M | -4% |
| EBITDA | SEK 226K | -28% |
| Net profit | SEK 180K | -27% |
| Total assets | SEK 605K | +10% |
| Equity | SEK 454K | +21% |
| Employees | 1 | — |
Legal name
Nexborn Fysioterapi AB
Org number
5569814089
Legal form
Aktiebolag
NACE code
8695 · Physiotherapy activities
Founded
2 september 2014
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Föremålet för bolagets verksamhet är att bedriva sjukgymnastik, föreläsningar inom rehabilitering samt försäljning av rehabprodukter och därmed förenlig verksamhet.
Address
Stampgatan 64 Lght 1601
Email
nexborn@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 171 | 1 237 | 1 324 | 1 378 | 1 325 |
| Staff expenses | — | −621 | −640 | −628 | −643 |
| EBITDA | 301 | 245 | 257 | 313 | 226 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 301 | 245 | 257 | 313 | 226 |
| Net financials | — | −1 | 2 | −1 | 0 |
| Profit before tax | 301 | 243 | 259 | 312 | 226 |
| Tax | −28 | −50 | −53 | −65 | −47 |
| Net profit | 273 | 193 | 206 | 248 | 180 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 386 | 440 | 452 | 552 | 605 |
| Equity | 228 | 321 | 327 | 374 | 454 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 158 | 119 | 125 | 177 | 151 |
| Total debt | 158 | 119 | 125 | 177 | 151 |
EBITDA margin
17.1%
This company
15.8%
Market median
+8% vs market
20212025
Equity ratio
75.0%
This company
38.2%
Market median
+96% vs market
20212025
Return on equity
39.6%
This company
18.4%
Market median
+115% vs market
20212025
Net profit margin
13.6%
This company
8.1%
Market median
+68% vs market
20212025
Asset turnover
2.19×
This company
1.12×
Market median
+96% vs market
20212025
Debt / equity
0.33×
This company
0.62×
Market median
+47% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Nexborn Fysioterapi AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Erik Erland Nexborn | Board of Directors | 0 companies |
| Nina Lilotte Bjarnesdotter Nexborn | Deputy Board Member | 0 companies |